These observations illustrated the effect of diosmetin on inhibiting cell proliferation, inducing G2/M cell cycle arrest and apoptosis via STAT3/c-Myc signaling pathway, which suggesting that it might be a new potential candidate for osteosarcoma treatment. The gene discussed is MYC; the disease is osteosarcoma.